Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction

Journal of the American College of Cardiology

Volumn 67, Issue 21, 2016, Pages 2480-2487

  Mody, Purav ^a   Joshi, Parag H ^a,b   Khera, Amit ^a   Ayers, Colby R ^a,c   Rohatgi, Anand ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cholesterol efflux capacity; coronary artery calcium; family history; high density lipoprotein; risk prediction

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL EFFLUX CAPACITY; CHOLESTEROL TRANSPORT; CORONARY ARTERY CALCIUM SCORE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; BLOOD VESSEL CALCIFICATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; FOLLOW UP; GENETIC PREDISPOSITION; HEART MUSCLE REVASCULARIZATION; METABOLISM; MYOCARDIAL INFARCTION; STROKE; TEXAS; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; C-REACTIVE PROTEIN; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RISK ASSESSMENT; STROKE; TEXAS; VASCULAR CALCIFICATION;

EID: 84970004980     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.538     Document Type: Article

References (34)

1. G.G. Schwartz, A.G. Olsson, M. Abt, and et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome N Engl J Med 367 2012 2089 2099
2. W.E. Boden, J.L. Probstfield, T. Anderson, and et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
3. J.R. Guyton, A.E. Slee, T. Anderson, and et al. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes) J Am Coll Cardiol 62 2013 1580 1584
4. R.H. Mackey, P. Greenland, D.C. Goff Jr., D. Lloyd-Jones, C.T. Sibley, and S. Mora High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 60 2012 508 516
5. A. Rohatgi, A. Khera, J.D. Berry, and et al. HDL cholesterol efflux capacity and incident cardiovascular events N Engl J Med 371 2014 2383 2393
6. A.J. Vallejo-Vaz, and K.K. Ray Cholesterol efflux capacity as a novel biomarker for incident cardiovascular events: has high-density lipoprotein been resuscitated? Circ Res 116 2015 1646 1648
7. A.V. Khera, M. Cuchel, M. de la Llera-Moya, and et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
8. D. Saleheen, R. Scott, S. Javad, and et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study Lancet Diabetes Endocrinol 3 2015 507 513
9. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, and et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines J Am Coll Cardiol 63 2014 2935 2959
10. J. Perk, G. De Backer, H. Gohlke, and et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 33 2012 1635 1701
11. J. Yeboah, R.L. McClelland, T.S. Polonsky, and et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals JAMA 308 2012 788 795
12. R.G. Victor, R.W. Haley, D.L. Willett, and et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health Am J Cardiol 93 2004 1473 1480
13. R. Deo, A. Khera, D.K. McGuire, and et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J Am Coll Cardiol 44 2004 1812 1818
14. B. Philips, J.A. de Lemos, M.J. Patel, D.K. McGuire, and A. Khera Relation of family history of myocardial infarction and the presence of coronary arterial calcium in various age and risk factor groups Am J Cardiol 99 2007 825 829
15. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870
16. A. Khera, G.L. Vega, S.R. Das, and et al. Sex differences in the relationship between C-reactive protein and body fat J Clin Endocrinol Metab 94 2009 3251 3258
17. C.D. Maroules, E. Rosero, C. Ayers, R.M. Peshock, and A. Khera Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas Heart Study Radiology 269 2013 84 91
18. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
19. M.A. Hlatky, P. Greenland, D.K. Arnett, and et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
20. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
21. M.J. Pencina, R.B. D'Agostino, and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
22. J.K. Gronnesby, and O. Borgan A method for checking regression models in survival analysis based on the risk score Lifetime Data Anal 2 1996 315 328
23. R. Detrano, A.D. Guerci, J.J. Carr, and et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 2008 1336 1345
24. T.S. Polonsky, R.L. McClelland, N.W. Jorgensen, and et al. Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA 303 2010 1610 1616
25. R. Erbel, S. Mohlenkamp, S. Moebus, and et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study J Am Coll Cardiol 56 2010 1397 1406
26. A.R. Paixao, J.D. Berry, I.J. Neeland, and et al. Coronary artery calcification and family history of myocardial infarction in the Dallas Heart Study J Am Coll Cardiol Img 7 2014 679 686
27. M. Nielsen, C. Andersson, T.A. Gerds, and et al. Familial clustering of myocardial infarction in first-degree relatives: a nationwide study Eur Heart J 34 2013 1198 1203
28. M.F. Ranthe, J.A. Petersen, H. Bundgaard, J. Wohlfahrt, M. Melbye, and H.A. Boyd A detailed family history of myocardial infarction and risk of myocardial infarction-a nationwide cohort study PloS One 10 2015 e0125896
29. P.M. Ridker, N.P. Paynter, N. Rifai, J.M. Gaziano, and N.R. Cook C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251 4p following 2251
30. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
31. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
32. A. Ritsch, H. Scharnagl, and W. Marz HDL cholesterol efflux capacity and cardiovascular events N Engl J Med 372 2015 1870 1871
33. J.M. Murabito, B.H. Nam, R.B. D'Agostino Sr., D.M. Lloyd-Jones, C.J. O'Donnell, and P.W. Wilson Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study Ann Intern Med 140 2004 434 440
34. M.J. Leening, M.M. Vedder, J.C. Witteman, M.J. Pencina, and E.W. Steyerberg Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide Ann Intern Med 160 2014 122 131